(Q46299618)

21 December 2017

title

The Q121 variant of ENPP1 may protect from childhood overweight/obesity in the Italian population (English)

1 reference

21 December 2017

0 references

0 references

5

1 reference

21 December 2017

Philippe Froguel

6

1 reference

21 December 2017

David Meyre

7

object named as

David Meyre

1 reference

21 December 2017

author name string

Anita Morandi

1

1 reference

21 December 2017

Leonardo Pinelli

2

1 reference

21 December 2017

Antonio Petrone

3

1 reference

21 December 2017

Vincent Vatin

4

1 reference

21 December 2017

publication date

23 October 2008

1 reference

21 December 2017

published in

Obesity

1 reference

21 December 2017

volume

17

1 reference

21 December 2017

page(s)

202-206

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42,042 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

The Q121/Q121 genotype of ENPP1/PC-1 is associated with lower BMI in non-diabetic whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Association of K121Q polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Establishing a standard definition for child overweight and obesity worldwide: international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Genetics of obesity and type 2 diabetes: tracking pathogenic traits during the predisease period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Haplotype structure of the ENPP1 Gene and Nominal Association of the K121Q missense single nucleotide polymorphism with glycemic traits in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Common Variants in the ENPP1 Gene Are Not Reproducibly Associated With Diabetes or Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

ACDC/Adiponectin Polymorphisms Are Associated With Severe Childhood and Adult Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

ENPP1Variants and Haplotypes Predispose to Early Onset Obesity and Impaired Glucose and Insulin Metabolism in German Obese Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

No Evidence of Association of ENPP1 Variants With Type 2 Diabetes or Obesity in a Study of 8,089 U.K. Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

The Pleiotropic Effect of theENPP1(PC-1) Gene on Insulin Resistance, Obesity, and Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.470

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.470

1 reference

21 December 2017

PubMed ID

18948963

1 reference

21 December 2017